Once, twice, three times a listing
Subscribe to keep reading.
Trivium Markets keeps you briefed on the latest developments in China markets policy.
Already a subscriber? Log in.
On Tuesday, the Chinese Securities Regulatory Commission (CSRC) approved Beijing and Massachusetts-based biotech firm BeiGene for listing on the Shanghai Stock Exchange Science and Technology Innovation Board (STAR Market).
BeiGene is apparently loco for listings:
The company is already traded on t...